Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive...

Next-gen cybersecurity tool looks to revolutionize information security by leveraging the BSV blockchain LONDON, June 2, 2023 /PRNewswire/ -- Yesterday, at the London Blockchain Conference,...

The 6th (Cangzhou) Garden Exposition of Hebei Province kicked off on May 26 in Cangzhou, China's northern city that thrives on canal. A total 19 activities in five categories, including academic...

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences: Jefferies Healthcare Conference Wednesday, June 7 at 12:30 p.m. EDT

New analyses from the Phase 3 monarchE trial of two years of Verzenio treatment in node-positive, high risk early breast cancer show similar efficacy across age groups and in patients who had dose...